Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis
Journal Article
·
· Biochemical and Biophysical Research Communications
OSTI ID:20979824
- Department of Medicine, Duke University School of Medicine, DUMC Box 3912, Durham, NC 27710 (United States)
The cardiotoxic adverse effects of anthracycline antibiotics limit their therapeutic utility as essential components of chemotherapy regimens for hematologic and solid malignancies. Here we show that the hematopoietic cytokine erythropoietin attenuates doxorubicin-induced apoptosis of primary neonatal rat ventricular cardiomyocytes in a dose-dependent manner. Erythropoietin treatment induced rapid, time-dependent phosphorylation of MAP kinases (MAPK) Erk1/2 and the phosphatidylinositol 3-kinase substrate Akt. Treatment of cardiomyocytes with inhibitors of phosphatidylinositol 3-kinase (LY294002) or Akt (Akti-1/2) abolished the protective effect of erythropoietin, whereas treatment with MAPK kinase (MEK1) inhibitor U0126 did not. Erythropoietin also induced the phosphorylation of GSK-3{beta}, a downstream target of PI3K-Akt. Because phosphorylation is known to inactivate GSK-3{beta}, we investigated whether GSK-3{beta} inhibition is cardioprotective. We found that GSK-3{beta} inhibitors SB216763 or lithium chloride blocked doxorubicin-induced cardiomyocyte apoptosis in a manner similar to erythropoietin, suggesting that GSK-3{beta} inhibition is involved in erythropoietin-mediated cardioprotection. Erythropoietin may serve as a novel cardioprotective agent against anthracycline-induced cardiotoxicity.
- OSTI ID:
- 20979824
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 354; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis
Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt
Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition
Journal Article
·
Fri Sep 01 00:00:00 EDT 2006
· Biochemical and Biophysical Research Communications
·
OSTI ID:20854441
Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt
Journal Article
·
Sun Nov 01 00:00:00 EDT 2015
· Toxicology and Applied Pharmacology
·
OSTI ID:22687795
Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition
Journal Article
·
Wed Dec 14 23:00:00 EST 2016
· Toxicology and Applied Pharmacology
·
OSTI ID:22690884